However, in transgenic mice, overexpression of miR-17-92 inhibits tumor growth and tumor angiogenesis by targeting multiple genes, such as transforming growth factor β type II receptor, hypoxia induced factor-1α and vascular endothelial growth factor A [44]. Here, VEGFA is linked to neoplasm.